|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
2002-4-9
|
|
pubmed:abstractText |
Mutations in the type II receptor for bone morphogenetic protein (BMPR-II), a receptor member of the transforming growth factor-beta (TGF-beta) superfamily, underlie many familial and sporadic cases of primary pulmonary hypertension (PPH).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Activin Receptors, Type I,
http://linkedlifedata.com/resource/pubmed/chemical/BMPR2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Bone Morphogenetic Protein...,
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Transforming Growth...,
http://linkedlifedata.com/resource/pubmed/chemical/TGF-beta type I receptor,
http://linkedlifedata.com/resource/pubmed/chemical/transforming growth factor-beta...
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
9
|
|
pubmed:volume |
105
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1672-8
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:11940546-Activin Receptors, Type I,
pubmed-meshheading:11940546-Adult,
pubmed-meshheading:11940546-Biological Markers,
pubmed-meshheading:11940546-Bone Morphogenetic Protein Receptors, Type II,
pubmed-meshheading:11940546-DNA Mutational Analysis,
pubmed-meshheading:11940546-Endothelium, Vascular,
pubmed-meshheading:11940546-Female,
pubmed-meshheading:11940546-Heterozygote,
pubmed-meshheading:11940546-Humans,
pubmed-meshheading:11940546-Hypertension, Pulmonary,
pubmed-meshheading:11940546-Immunohistochemistry,
pubmed-meshheading:11940546-In Situ Hybridization,
pubmed-meshheading:11940546-Lung,
pubmed-meshheading:11940546-Male,
pubmed-meshheading:11940546-Middle Aged,
pubmed-meshheading:11940546-Mutation,
pubmed-meshheading:11940546-Organ Specificity,
pubmed-meshheading:11940546-Protein-Serine-Threonine Kinases,
pubmed-meshheading:11940546-Pulmonary Circulation,
pubmed-meshheading:11940546-RNA, Messenger,
pubmed-meshheading:11940546-Receptors, Transforming Growth Factor beta
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.
|
|
pubmed:affiliation |
Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Cambridge, UK.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
